References
- Paunescu E. In vivo and in vitro suppression of humoral and cellular response by rifampicin. Nature. 1970;229:1188–1189.
- Nilsson BS. Rifampicin: An immunosuppressant? Lancet. 1971;ii:374.
- Gupta S, Grieco MH, Siegel I. Suppression of T-lymphocyte rosettes by Rifampicin. Studies in normals and patients with tuberculosis. Ann Int Med. 1975;82:484–488.
- Mlambo G, Sigola LB. Rifampicin and dexamethasone have similar effects on macrophage phagocytosis of zymosan, but differ in their effects on nitrite and TNF-alpha production. Int Immunopharmacol. 2003;3:513–522.
- Ziglam HM, Daniels I, Finch RG. Immunomodulating activity of rifampicin. J Chemother. 2004;16:357–361.
- Calleja C, Pascussi JM, Mani JC, Maurel P, Vilarem MJ. The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nat Med. 1998;4:92–96.
- Tsankov N, Krasteva M. Rifampin in severe forms of psoriasis. J Dermatol Treat. 1992;3:69–71.
- Tsankov NK, Kamarashev JA. Rifampin. Int J Dermatol. 1993;32:401–406.
- Tsankov N, Krasteva M. On rifampin treatment of psoriasis. J Am Acad Dermatol. 1993;29(6):1057 [letter].
- Kazandjieva J, Kamarashev J, Hinkov G. Alleviation of psoriasis by rifampicin in treatment of pulmonary tuberculosis. J Dermatolog Treat. 1993;4:163–165 [letter].
- Kаzandjieva J, Kamarashev J, Hinkov G, Tsankov N. Rifampicin und Psoriasis. Akt Dermatol. 1997;23:78–81.
- Tsankov N. Drug therapy in patients with psoriasis vulgaris – risks and perspectives [Thesis]. Medical Faculty, Sofia; 1996.
- Grozdev I, Kazandjieva J, Tsankov N. Rifampicin in eruptive psoriasis. J Eur Acad Dermatol Venereol. 2004;18(suppl 1):57–58 [abstract].
- Grozdev I, Kazndjieva J, Tsankov N. Use of rifampicin for the treatment of psoriasis. J Eur Acad Dermatol Venereol. 2004;18(suppl 2):268–269 [abstract].
- Tsankov N, Kazandjieva J, Grozdev I. Treatment of psoriasis with rifampicin. Is rifampicin an immunosuppressive antibiotic? European Congress on Psoriasis, Paris, 21–24 October 2004 [poster presentation].
- Tsankov N, Grozdev I. Rifampicin as treatment strategy for psoriasis: Benefits and risks. 2nd International Congress on Psoriasis, Paris, 21–24 June 2007 [oral presentation].
- Tsankov N, Grozdev I, Kazandjieva J. Old drug – New indication. Rifampicin in psoriasis. J Dermatolog Treat. 2006;17(1):18–23.
- Tsankov N, Grozdev I. Rifampicin in treatment of psoriasis. J Eur Acad Dermatol. 2009;23(1):93–95.